• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Adv . Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces

tetano

Editor, Senior Moderator
Sci Adv


. 2022 Feb 25;8(8):eabm3608.
doi: 10.1126/sciadv.abm3608. Epub 2022 Feb 25.
Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces


Laura C Rosella[SUP] 1 [/SUP], Ajay Agrawal[SUP] 2 3 [/SUP], Joshua Gans[SUP] 2 3 [/SUP], Avi Goldfarb[SUP] 2 3 [/SUP], Sonia Sennik[SUP] 3 [/SUP], Janice Stein[SUP] 4 [/SUP]



Affiliations

Abstract

The transmission of coronavirus disease 2019 (COVID-19) in workplaces has been a persistent issue throughout the pandemic. In response, a not-for-profit initiative emerged to mitigate COVID-19 workplace transmission in Canada. We report the process for establishing a workplace frequent rapid antigen test (RAT) program. The screening program identified 473 asymptomatic individuals who tested positive on the RAT and confirmed positive by a nasopharyngeal polymerase chain reaction (PCR) diagnostic test. One in 4300 RATs was presumptive positive but later tested PCR negative, and thus, false positives did not meaningfully disrupt workplace operations. Most employers rated the program highly and felt strongly that the program contributed to workplace and community safety. The findings describe a sustained and scalable implementation plan for establishing a frequent workplace testing program. High-frequency testing programs offer the potential to break chains of transmission and act as an extra layer of protection in a comprehensive public health response.
 
Back
Top Bottom